Abstract
Antibiotic resistance has presented a major health challenge in the world and many isolates of Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa become resistant to almost all current antibiotics. This chapter provides an overview on the mechanisms of antibiotic resistance in these Gram-negative pathogens and outlines the formidable problem of the genetics of bacterial resistance. Prevalent multidrug-resistance in Gram-negative bacteria underscores the need for optimizing the clinical use of the last-line polymyxins.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Magill SS, Edwards JR, Bamberg E et al (2014) Multistate point prevalence survey of healthcare-associated infections. N Engl J Med 370:1198–1208
Peleg AY, Hooper DC (2010) Hospital-acquired infections due to Gram-negative bacteria. N Engl J Med 362:1804–1813
Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K (1997) Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41:563–569
World Health Organization (WHO) (2017) WHO priority pathogens list for R&D of new antibiotics [Online]. Available: http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1. Accessed 28 Apr 2019
Yigit H, Queenan AM, Anderson GJ et al (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161
Tumbarello M, Losito AR, Giamarellou H (2018) Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections. Curr Opin Infect Dis 31:566–577
Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, Hamula CL, Uhlemann AC, Levi MH, Fries BC, Tang YW, Juretschko S, Rojtman AD, Hong T, Mathema B, Jacobs MR, Walsh TJ, Bonomo RA, Kreiswirth BN (2017) Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States. Antimicrob Agents Chemother 61: pii: e02349–16
Navon-Venezia S, Leavitt A, Schwaber MJ et al (2009) First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 53:818–820
Yong D, Toleman MA, Giske CG et al (2009) Characterization of a new metallo-β-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054
Wailan AM, Paterson DL (2014) The spread and acquisition of NDM-1: a multifactorial problem. Expert Rev Anti-Infect Ther 12:91–115
Castanheira M, Deshpande LM, Farrell SE, Shetye S, Shah N, Jones RN (2013) Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010. Diagn Microbiol Infect Dis 75:210–213
Poirel L, Potron A, Nordmann P (2012) OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 67:1597–1606
Zowawi HM, Balkhy HH, Walsh TR, Paterson DL (2013) β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev 26:361–380
Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538–582
Paton R, Miles RS, Hood J, Amyes SG, Miles RS, Amyes SG (1993) ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2:81–87
Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL (2006) The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258:72–77
Walsh TR, Toleman MA, Poirel L, Nordmann P (2005) Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 18:306–325
Gottig S, Gruber TM, Higgins PG, Wachsmuth M, Seifert H, Kempf VA (2014) Detection of pan drug-resistant Acinetobacter baumannii in Germany. J Antimicrob Chemother 69:2578–2579
Bonomo RA, Szabo D (2006) Mechanisms of multidrug resistance in Acinetobacter spp. and Pseudomonas aeruginosa. Clin Infect Dis 43(Suppl 2):S49–S56
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161–168
Schwarz S, Johnson AP (2016) Transferable resistance to colistin: a new but old threat. J Antimicrob Chemother 71:2066–2070
Wise MG, Estabrook MA, Sahm DF, Stone GG, Kazmierczak KM (2018) Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014–2016 as part of the INFORM global surveillance program. PLoS One 13:e0195281
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Paterson, D.L., Bonomo, R.A. (2019). Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for ‘Old’ Polymyxins. In: Li, J., Nation, R., Kaye, K. (eds) Polymyxin Antibiotics: From Laboratory Bench to Bedside. Advances in Experimental Medicine and Biology, vol 1145. Springer, Cham. https://doi.org/10.1007/978-3-030-16373-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-16373-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16371-6
Online ISBN: 978-3-030-16373-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)